Dear Colleagues,
It is our pleasure to invite you to the 53rd Annual Meeting of the Scandinavian Society for the Study of Diabetes (SSSD) in Turku, Finland, 11-13 April 2018.
The objective of the Annual Meeting of SSSD is to give diabetes researchers and clinicians in the Nordic and neighbouring countries an opportunity to meet and discuss clinical and experimental diabetes research.
For the symposia, we have invited lecturers to cover both clinical themes and cutting edge basic science. In addition, it has always been the aim of the annual meetings of SSSD to enable researchers to orally present and discuss research projects.
Abstract submission deadline is on 29th January 2018. Travel grants are available.
We hope that many of you will be able to participate and look forward to seeing you in Turku!
Award lecturers, invited speakers and topics are listed below:
Knud Lundbæk award lecture
Valdemar Grill, Norwegian University of Science and Technology, Trondheim, Norway
Friends and foes of the pancreatic beta cell - implications for treatment
Novo Nordisk award lecture
Olle Korsgren, Uppsala University, Sweden
On the etiology of Type 1 Diabetes: lessons learned from the human pancreas
Barndiabetesfonden Johnny Ludvigsson award lecture
Pål Njölstad, University of Bergen, Norway
Type 2 diabetes - Title open
Jorma Ilonen, University of Turku, Finland - Prediction of T1D - genes, autoantibodies and heterogeneity
Riitta Lahesmaa, University of Turku, Finland - Early signs of T1D
Riitta Veijola, University of Oulu, Finland - Prevention of type 1 diabetes
Chantal Mathieu, KU Leuven, Belgium - New molecular mechanisms of T1D - basis for prevention
Päivi Keskinen, Tampere University Hospital, Finland - Treatment and monitoring of type 1 diabetes, current view and future prospects
Mark Peakman, King's College Hospital, UK - Immunotherapy in T1D
Mikael Knip, University of Helsinki, Finland - Microbiome and type 1 diabetes
Malin Flodström Tullberg, Karolinska Instutute, Sweden - Viruses and type 1 diabetes
Arno Hänninen, University of Turku, Finland - Effect of gut dysbiosis to the development of autoimmunity
Ele Ferranini, University of Pisa, Italy - SGLT2 inhibitors: cardiovascular outcomes
Markku Laakso, University of Eastern Finland, Finland - Statins and risk of diabetes
Kirsi Pietiläinen, University of Helsinki, Finland - Obesity and type 2 diabetes
Filip Knop, University of Copenhagen, Denmark - The endocrine gut and its involvement in glucose homeostasis
Tina Visboll, University of Copenhagen, Denmark - Diabetes and cardiovascular disease: glucagon-like peptide-1 based therapies
Pirjo Nuutila, University of Turku, Finland - GLP-1 receptor based detection of beta cells
Merja Laine, University of Helsinki, Finland - Physical activity in young adulthood and risk of type 2 diabetes later in life
Kumail Motiani, University of Turku, Finland - Effects of short-term exercise training on intestinal metabolism and gut microbiota
More information can be found in 
We warmly welcome You to our meeting and hope to meet You in Turku!
Yours sincerely,
Organizing Committee
Johanna Lempainen, University of Turku
Lassi Nelimarkka, University of Turku
Liisa Saarikoski, University of Turku
Jarna Hannukainen, University of Turku
Scientific board
Markku Laakso, University of Eastern Finland
Pirjo Nuutila, University of Turku
Tapani Rönnemaa, University of Turku
Arno Hänninen, University of Turku
Mikael Knip, University of Helsinki
Riitta Lahesmaa, University of Turku
Outi Vaarala, University of Helsinki, AstraZeneca
Riitta Veijola, University of Oulu
www red DiabetologNytt